---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "/hqRy6tqPiLge09srwXVRmFHrJcs4z0Kg2rZQIhMM87vU8UkLCu6Ha5fykpylJau1u6u0NigreN9wg2DO4Q+uyzyNZQ4f+IAI7xZZ3JWdzUIXtGSqcvXXzrASAjEbLG3DCjTU6+jgMfgl63r+3bTJO9m3fiJ/loGiGjDU8H0MgLswEmZ01NfaCwUydb74+OmoFzJK6zJ/95zlrKMTaKhd+Pa/tweOhSndw68ldzC+bVUiRQRWrr9SfPpI/jbI5syj869Kt4UK+VhmCkFJP0pvxd3MYWR3ytlmj1Mu65l5xLxdkcz61rtuPhlR6rJnckh2YCdq6EHicVLNQjAKj0RQrhgKoNsNk1HeM4Zj9awKw4=;Rxh9UAiDw8LS+ipQlrfNAw=="
---

